Lidin Songo
Analyst
Leerink
Equibles does not estimate personal net worth.
About Lidin Songo
Lidin Songo is recorded as Analyst at Leerink. Lidin Songo has spoken on 1 investor event across 1 company, most recently for Rocket Pharmaceuticals, Inc. on March 27, 2026. The companies whose calls Lidin Songo spoke on are classified in the Healthcare sector.
Lidin Songo on recent calls
“Can you remind us the estimated size of the addressable market given the approval in patients with no HLA-matched donor sibling? And additionally, you mentioned a patient journey of four to five months.”
Affiliation history
-
Leerink
Analyst
Transcript header (unverified)
Current